Jose Espinosa, MD

Associate Professor, Department of Surgery

    About me

    Dr. Jose Espinosa is a neurosurgeon and Associate Professor in the Department of Surgery at Southern Illinois University School of Medicine.

    Dr. Espinosa completed his residency training at McGill University, Montreal Neurological Institute in 1994. During his residency, he was awarded the Penfield Award in Neurosurgery and the Francis McNaughton Scholarship.

    Dr. Espinosa has a special interest and surgical expertise in the treatment of epilepsy.  His research interests include utilizing state-of-the-art imaging techniques to access difficult areas of the brain. He is also interested in laboratory techniques that improve neuronal survival following injuries to the central nervous system.

    Dr. Espinosa has been awarded the J. Kiffin Penry Eagle Award for poineering new therapies in the treatment of epilepsy.  He is a life member of the National Registry of Who's Who.

    Dr. Espinosa is a fellow of the Royal College of Surgeons of Canada and is board certified in neurosurgery.

    For more information or to make an appointment with Dr. Espinosa, please call 217-545-8000.

    Remote video URL



    Education & training

    Board Certifications
    Medical School
    University of Panama, Republic of Panama
    McGill University-Montreal Neurological Institute, Montreal, Quebec, Canada - Neurosurgery
    McGill University-Montreal Neurological Institute, Montreal, Quebec, Canada - General Surgery


    Research Interests
    Epilepsy Surgery, Robotic Surgery, Brain Cancer, Back Surgery

    Clinical trials


    NX Corp.: A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas

    Active recruiting

    NXDC-MEN-301: Subjects are being asked to participate in this study because they have a brain tumor, a meningioma, and surgery is recommended to remove it.  The sponsor of this clinical trial, NX Development Corp, has developed the study drug, Gleolan, an imaging agent that in some brain tumors, can make the tumors glow red-violet under a special blue light. This may make it easier for the study surgeon to identify the tumor and to remove it.  As part of the study, subjects will drink the Gleolan before your surgery.  The goal is to safely remove the tumor.